RBC Capital Markets adjusted its financial outlook for Amazon.com, Inc. (NASDAQ:AMZN), raising the company's price target from $255.00 to $265.00. The firm maintained its Outperform rating on the ...
Good day, everyone, and welcome to today's Neurocrine Biosciences reports Q4 and fiscal year 2024 Earnings Call. (Operator Instructions) Please note today's call will be recorded and I will be ...